Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fabrazyme in Fabry Disease With Severe Renal Disease
NCT00837824Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Dec 2002
- Primary completion
- Aug 2003
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of agalsidase beta in Fabry disease (FD), sponsored by Sanofi. Started Dec 2002; status: terminated.
02
Drugs
agalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00837824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837824.